• HyperTrap Heparin HP Column: Precision Affinity for Stemness

  2026-05-24

  Explore how the HyperTrap Heparin HP Column empowers high-resolution purification of signaling proteins underlying cancer stem cell biology. This article uniquely connects affinity chromatography to practical choices in studying CCR7–Notch1 crosstalk.

• Balancing Self-Renewal and Differentiation in Human Intestin

  2026-05-23

  This study introduces a tunable human intestinal organoid system capable of achieving a controlled balance between stem cell self-renewal and differentiation without artificial niche gradients. The approach leverages small molecule pathway modulators to enhance cellular diversity and scalability, advancing the utility of organoids for high-throughput research.

• CCR7–Notch1 Crosstalk Drives Stemness in Mammary Cancer Cell

  2026-05-22

  Boyle et al. (2017) reveal crosstalk between CCR7 and Notch1 pathways as a key regulator of cancer stem-like cell maintenance in mammary tumors. This mechanistic insight not only advances understanding of breast cancer recurrence but also highlights new targets for therapeutic intervention against tumor stemness and therapy resistance.

• NF-κB p65–Mediated YAP Inactivation Drives Pyroptosis in UC

  2026-05-22

  This study elucidates how NF-κB p65 activation in ulcerative colitis promotes phosphorylation and inactivation of YAP, relieving repression of NLRP3 and exacerbating colonic epithelial pyroptosis. The findings offer mechanistic insight into the cross-talk between NF-κB signaling and Hippo pathway regulation during intestinal inflammation, highlighting potential therapeutic targets for inflammation research.

• AI-Driven Discovery of Senolytics: Machine Learning Advances

  2026-05-21

  The referenced study pioneers a machine learning approach to identify new senolytic compounds using only published data, significantly reducing drug screening costs. This method validates ginkgetin, periplocin, and oleandrin as potent senolytics, offering a scalable pathway for early-stage drug discovery in cancer and age-related disease research.

• 20-HETE–TRPV1–MrgprA3+ Axis Drives Itch Sensitization in Der

  2026-05-21

  This study elucidates how the lipid metabolite 20-HETE activates TRPV1 channels on MrgprA3+ sensory neurons, converting pain signals into itch in chronic dermatitis. The findings provide a mechanistic rationale for targeting this pathway to alleviate chronic itch, with implications for translational research in somatosensory disorders.

• Oxaliplatin: Applied Workflows and Resistance Solutions in C

  2026-05-20

  Oxaliplatin, a platinum-based chemotherapeutic agent, is central to preclinical cancer models and advanced chemotherapy resistance research. This article details best-practice workflows, actionable troubleshooting, and the latest mechanistic insights—empowering translational breakthroughs for apoptosis induction and DNA damage modeling.

• EV-Transferred ACLY Drives TAM Differentiation in HCC Progre

  2026-05-20

  This study demonstrates that hepatocellular carcinoma (HCC) cells secrete extracellular vesicles (EVs) containing ATP-citrate lyase (ACLY), which are preferentially taken up by monocytes and reprogram them toward immunosuppressive tumor-associated macrophages (TAMs). The findings reveal a distinct metabolic mechanism fueling HCC progression and highlight the therapeutic potential of targeting EV-transferred ACLY to enhance immunotherapy efficacy.

• EPZ-6438: Optimizing EZH2 Inhibitor Workflows for Cancer Res

  2026-05-19

  EPZ-6438 stands out as a highly selective EZH2 inhibitor, streamlining epigenetic cancer research with nanomolar potency and robust assay compatibility. This guide delivers actionable workflow enhancements, troubleshooting strategies, and expert insights for maximizing EPZ-6438 performance in both in vitro and in vivo models.

• Technical Guidance for Angiotensin I/II (1-5) in RAS Researc

  2026-05-19

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for modeling blood pressure regulation and aldosterone signaling within renin-angiotensin system (RAS) workflows. It is suited to cardiovascular and renal studies, but should not be used for unrelated peptide or exploratory signaling research due to its specific mechanism and solubility characteristics.

• Rotavirus Drives Nrf2 Downregulation and Redox Defense Colla

  2026-05-18

  This study demonstrates that progressive rotavirus infection leads to a marked downregulation of the redox-sensitive transcription factor Nrf2 and its downstream cytoprotective targets, independent of canonical redox or proteasomal control pathways. These insights highlight new complexities in host–virus interactions and provide a mechanistic foundation for further redox signaling research.

• Leupeptin Hemisulfate Salt: Precision Tools for Translationa

  2026-05-18

  Explore how Leupeptin hemisulfate salt enables next-generation studies of protease activity regulation, protein degradation, and viral replication inhibition. Integrating mechanistic insight with strategic guidance, this thought-leadership article demonstrates how APExBIO’s Leupeptin empowers translational researchers to bridge fundamental biochemistry and clinical innovation.

• Otilonium Bromide in Translational Research: Precision for C

  2026-05-17

  Explore the mechanistic depth and translational potential of Otilonium Bromide, a high-purity antimuscarinic agent. This thought-leadership article bridges biological rationale, experimental design, and strategic guidance, empowering researchers to leverage Otilonium Bromide for advanced neuroscience and smooth muscle studies.

• Anti-Diabetic Drugs and Fracture Risk: Insights from Network

  2026-05-16

  This systematic review and network meta-analysis rigorously evaluated the association between various anti-diabetic drugs and fracture risk in type 2 diabetes mellitus (T2DM) patients. While most agents, including SGLT2 inhibitors such as Ertugliflozin (PF-04971729), showed no significant effect on fracture risk, some drugs increased or decreased risk, highlighting the need for individualized therapeutic decisions.

• Strategic Cell Tracking in Inflammatory Disease: DiD (DiDC 1

  2026-05-15

  This thought-leadership article explores how DiD (DiDC 18 (5)) enables reliable plasma membrane labeling and cell tracking in translational models of inflammatory disease. Bridging mechanistic insight from recent advances in diabetic periodontitis with experimental and strategic guidance, it demonstrates how DiD's unique properties facilitate high-fidelity, immunofluorescence-compatible workflows even in challenging, high-autofluorescence tissue environments. The piece contextualizes APExBIO's DiD probe within the competitive landscape, offers actionable protocol parameters, and charts a forward-looking outlook for translational researchers.

522 records 15/35 page Previous Next First page 上5页 1112131415 下5页 Last page